. Are you planning on attending Global Engage’s virtual 7th Digital Pathology & AI Congress: EU? If so, make sure to check out our presentation on December 3rd as well as our virtual booth. If you aren’t able to attend, don’t...

REGISTER NOW Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei...

The Danish-based leader in augmented pathology solutions Visiopharm has secured a grant worth £250,000 from UK Research and Innovation to test its innovative solutions in partnership with the NHS. The grant, offered by the UK Government’s...

Visiopharm’s quantitative image analysis software suite uniquely offers a secure, scalable, agnostic platform that helps pathologists and researchers alike address the quality and cost challenges in drug discovery and cancer...

Courtesy of Dr. Michael Grunkin, CEO, Visiopharm What Is a Hot-Spot and Does It Matter? The importance of hot-spots As discussed in the recent post on managing tumor heterogeneity, it is widely considered best practice to determine the...

Webinar | AI Deep Learning – Easy Workflow, Automated Annotations, Powerful Use Cases Do you want to learn how easy it is to use AI in digital image analysis? In this webinar you’ll experience how you can use Visiopharm’s AI platform...